These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 15916920)

  • 1. Attenuation of postoperative noradrenaline need by nitric oxide inhibition using L-NMMA.
    Franco-Cereceda A; Holm P; Bredin F; Adding C
    Eur J Heart Fail; 2005 Dec; 7(7):1180-2. PubMed ID: 15916920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of local intra-arterial NG-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal.
    Calver A; Collier J; Moncada S; Vallance P
    J Hypertens; 1992 Sep; 10(9):1025-31. PubMed ID: 1328361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of nitric oxide synthesis in the forearm arterial bed of patients with advanced cirrhosis.
    Campillo B; Chabrier PE; Pelle G; Sediame S; Atlan G; Fouet P; Adnot S
    Hepatology; 1995 Nov; 22(5):1423-9. PubMed ID: 7590658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inducible nitric oxide synthase activity does not contribute to the maintenance of peripheral vascular tone in patients with heart failure.
    Dover AR; Chia S; Ferguson JW; Cruden NL; Megson IL; Fox KA; Newby DE
    Clin Sci (Lond); 2006 Oct; 111(4):275-80. PubMed ID: 16803456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of inhibition of nitric oxide synthase on dynamic cerebral autoregulation in humans.
    White RP; Vallance P; Markus HS
    Clin Sci (Lond); 2000 Dec; 99(6):555-60. PubMed ID: 11099400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide and cardiac parasympathetic control in human heart failure.
    Chowdhary S; Ng GA; Nuttall SL; Coote JH; Ross HF; Townend JN
    Clin Sci (Lond); 2002 Apr; 102(4):397-402. PubMed ID: 11914101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide synthase inhibition does not improve renal function in cirrhotic patients with ascites.
    Thiesson HC; Skøtt O; Jespersen B; Schaffalitzky de Muckadell OB
    Am J Gastroenterol; 2003 Jan; 98(1):180-6. PubMed ID: 12526955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of endothelin-1 on endothelium-derived vascular responsiveness in man.
    Krum H; Cranswick N; Pellizzer AM
    Clin Sci (Lond); 1998 Aug; 95(2):151-6. PubMed ID: 9680496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrarenal haemodynamics and renal dysfunction in endotoxaemia: effects of nitric oxide synthase inhibition.
    Millar CG; Thiemermann C
    Br J Pharmacol; 1997 Aug; 121(8):1824-30. PubMed ID: 9283724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide and the haemodynamic profile of endotoxin shock in the conscious mouse.
    Rees DD; Monkhouse JE; Cambridge D; Moncada S
    Br J Pharmacol; 1998 Jun; 124(3):540-6. PubMed ID: 9647479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a nitric oxide synthase inhibitor on pressor response to angiotensin II in conscious rats.
    Maeda T; Yoshimura T; Ohshige A; Koyama H; Ito M; Okamura H
    Artery; 1998; 23(1):1-9. PubMed ID: 10846613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of the nitric oxide synthase inhibitor L-NG-methylarginine hydrochloride in patients with septic shock. Glaxo Wellcome International Septic Shock Study Group.
    Hussein Z; Beerahee M; Grover R; Jordan B; Jeffs R; Donaldson J; Zaccardelli D; Colice G; Guntupalli K; Watson D; Vincent JL
    Clin Pharmacol Ther; 1999 Jan; 65(1):1-9. PubMed ID: 9951425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo evidence for nitric oxide-mediated calcium-activated potassium-channel activation during human endotoxemia.
    Pickkers P; Dorresteijn MJ; Bouw MP; van der Hoeven JG; Smits P
    Circulation; 2006 Aug; 114(5):414-21. PubMed ID: 16864730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide inhibition in the treatment of the sepsis syndrome is detrimental to tissue oxygenation.
    Statman R; Cheng W; Cunningham JN; Henderson JL; Damiani P; Siconolfi A; Rogers D; Horovitz JH
    J Surg Res; 1994 Jul; 57(1):93-8. PubMed ID: 8041156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo quantification of endotoxin-induced nitric oxide production in pigs from Na15NO3-infusion.
    Santak B; Radermacher P; Iber T; Adler J; Wachter U; Vassilev D; Georgieff M; Vogt J
    Br J Pharmacol; 1997 Dec; 122(8):1605-10. PubMed ID: 9422804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forearm vasoconstriction in response to noradrenaline and NG-monomethyl-L-arginine in essential hypertension.
    Kneale BJ; Chowienczyk PJ; Brett SE; Cockcroft JR; Ritter JM
    Clin Sci (Lond); 1999 Sep; 97(3):277-82. PubMed ID: 10464052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of central nitric oxide to the regulation of blood pressure and sodium balance in DOCA-salt hypertension.
    Seto S; Nagao S; Ozeki S; Tetsuo H; Akahoshi M; Yano K
    J Cardiovasc Pharmacol; 2006 May; 47(5):680-5. PubMed ID: 16775508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noradrenaline and nomega-monomethyl-L-arginine (L-NMMA): effects on haemodynamics and regional blood flow in healthy and septic sheep.
    Booke M; Hinder F; McGuire R; Traber LD; Traber DL
    Clin Sci (Lond); 2000 Feb; 98(2):193-200. PubMed ID: 10657275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case report: new treatment with Tolvaptan for heart failure after cardiac surgery.
    Sezai A; Iida M; Yoshitake I; Osaka S; Hata H; Shiono M
    Heart Surg Forum; 2014 Aug; 17(4):E198-200. PubMed ID: 25179972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of psoriasis with topical NG-monomethyl-L-arginine, an inhibitor of nitric oxide synthesis.
    Ormerod AD; Copeland P; Shah SA
    Br J Dermatol; 2000 May; 142(5):985-90. PubMed ID: 10809860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.